Author:
Maltsev Dmitry V.,Spasov Alexander A.,Skripka Maria O.,Miroshnikov Mikhail V.,Divaeva Lyudmila N.,Morkovnik Anatoly S.,Zubenko Alexander A.,Klimenko Alexander I.
Abstract
The anxiolytic effect of a new series of C2,C3-quinoxaline derivatives was studied using the "Anxious-phobic state" and "Light/Dark chamber" techniques in comparison with diazepam. It was noted that the presence of a phenyl substituent at the C3 position, which did not contain elements with a distinct electronegativity, as well as 2-methyl-(4,5-dimethoxyphenyl)-N-methylethane-1-amine at the C2 position, had a positive effect on the manifestation of the antianxiety activity of new derivatives of C2,C3-quinoxaline. For the most active compound under the code ZDM-4, the conflict method "Vogel Conflict test" was additionally carried out to confirm the anxiolytic effect of the substance. The tranquiLizing potential of the ZDM-4 compound is of interest for further study.
Publisher
Volgograd State Medical University
Subject
Anesthesiology and Pain Medicine